Clicky

Wednesday, January 20th, 2021

Emerging Infectious Diseases

FDA approves Ebolavirus treatment Ebanga

The U.S. Food and Drug Administration (FDA) approved a treatment for the Zaire Ebolavirus infection in adults and children. The treatment is called Ebanga, a human monoclonal antibody that blocks the virus's binding to the cell receptor, thus preventing its entry into the cell. Zaire... Read More »

Senators applaud DHS for combatting vaccine fraud

A group of U.S. Senators is commending the Department of Homeland Security (DHS) and Homeland Security Investigations (HSI) for their efforts to protect against counterfeit vaccines and personal protective equipment through Operation Stolen Promise 2.0. “In April U.S. Immigration and Customs... Read More »

WHO, Sanofi renew tropical disease focus

World Health Organization (WHO) personnel and officials representing Sanofi, one of the world’s leading pharmaceutical companies, said the entities are partnering to readdress neglected tropical diseases (NTDs). “This decades-long collaboration exemplifies a successful public–private... Read More »

Tests address public transit virus spread reduction

Three entities have initiated real-world testing efforts to determine the most effective measures to address the public transit virus spread reduction. The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has partnered with the New York Metropolitan... Read More »

Researchers maintain LED lighting kills coronavirus

Tel Aviv University (TAU) researchers maintain the coronavirus can be killed efficiently, quickly, and cheaply using ultraviolet (UV) light-emitting diodes (UV-LEDs). Scientists believe the UV-LED technology would soon be available for private and commercial use, suggesting installation in air... Read More »

NIH funds target Zika vaccine development

The National Institutes of Health (NIH) has awarded a $2 million R01 grant to a Virginia Tech research team to develop a single-dose Zika virus vaccine candidate. "This grant focuses on a new strategy that we developed to produce safe and effective flavivirus vaccines," Jonathan Auguste, an... Read More »